The 10,000 steps target came from a marketing campaign. Here is the real number.

Ten thousand is on your phone, on your watch, in your workplace wellbeing scheme and in every step challenge you have ever been invited to join. It has the shape of a scientific recommendation: round, specific, universal.

It is none of those things. The figure is generally traced to a Japanese pedometer marketed in the mid-1960s under the name manpo-kei — literally, ten-thousand-step meter. It was a product name. The research came decades later, and when it arrived it said something more useful.

What the research actually shows

The clearest evidence comes from a 2022 meta-analysis in The Lancet Public Health, led by Amanda Paluch and the Steps for Health Collaborative. It pooled participant-level data from 15 international cohorts covering nearly 50,000 adults, with steps measured by accelerometer rather than recalled.

Participants were split into four groups by average daily steps: roughly 3,500, 5,800, 7,800 and 10,900.

The three more active groups had a 40% to 53% lower risk of death than the least active group.

Look closely at that sentence, because the interesting part is what it does not say. The gap between the bottom group and the second group — between 3,500 and 5,800 steps — captures a large share of the total benefit. The gap between 7,800 and 10,900 captures very little.

Where the curve flattens

The meta-analysis modelled the dose-response relationship and found the plateau falls in different places depending on age.

For adults aged 60 and over, mortality risk stopped improving at roughly 6,000 to 8,000 steps a day. For adults under 60, at roughly 8,000 to 10,000.

An earlier study of older women, led by I-Min Lee, had found a plateau at about 7,500 — a close match from an independent dataset.

So ten thousand is not wrong, exactly. For a younger adult it sits at the upper edge of the useful range. For anyone over sixty it is well past the point where additional steps stop buying additional years.

Why this matters more than it sounds

An unreachable target does not motivate. It gets abandoned.

If you are sixty-five and currently walking 4,000 steps, “ten thousand” is a number you will fail to hit most days, and the psychology of missing a target every day is not neutral — it teaches you that the whole enterprise is not for you.

Whereas 6,000 is achievable, is where the evidence says the curve flattens for your age group, and represents a genuinely large reduction in risk from where you are now.

The same logic runs the other way for anyone already at 12,000 who feels they should be pushing for 15,000. On mortality, the data suggests you have collected what there is to collect. If you walk more because you enjoy it, that is an excellent reason. It is just not buying additional years.

What about walking faster?

This is where the study got more interesting than expected.

After adjusting for total daily steps, the researchers looked at whether intensity added anything. The peak 30-minute cadence and peak 60-minute cadence were both associated with lower mortality — hazard ratios of 0.67 in each case, comparing the fastest quarter with the slowest.

But time spent walking above 40 steps per minute, or above 100 steps per minute, showed no significant association once total steps were accounted for.

The reasonable reading is that total volume does most of the work, and pace adds something at the margins rather than transforming the picture. Whether faster walking is causing the benefit, or simply marking out people who are more capable to begin with, the study cannot say.

The caveats

All of this is observational. Step counts were measured objectively, which removes one large source of error, but the design still cannot rule out that people who walk more are healthier for reasons that also make them walk more.

The direction of the effect is also not obvious in advance: early illness reduces walking long before it produces a diagnosis. Analyses of this kind typically exclude deaths in the first year or two to reduce that problem, and the association survives, but it does not vanish entirely.

And mortality is only one outcome. A separate body of work links higher step counts to lower rates of depression, cardiovascular events and dementia, with curves that do not necessarily flatten in the same place. Steps are not a single-purpose intervention with one optimal dose.

What to take away

If you are over sixty, aim at 6,000 to 8,000 and treat that as a full target rather than a compromise. If you are under sixty, 8,000 or so puts you where the evidence flattens.

If you are currently below 4,000, the single most valuable thing on this entire page is that the biggest gain available to anyone is the move from very little to moderate. Not from moderate to a lot.

That pattern shows up repeatedly in longevity research, and it runs against how most people think about health. The instinct is that more must be better and the serious gains lie at the demanding end. Usually the demanding end is where the returns run out, and the transformative bit happened much earlier — at the point somebody stopped doing almost nothing.

---

This article is for general information and is not medical advice.

Sources

1. Paluch AE, Bajpai S, Bassett DR, et al. Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. The Lancet Public Health, 2022;7(3):e219–e228. https://pubmed.ncbi.nlm.nih.gov/35247352/
2. Full text: https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(21)00302-9/fulltext
3. Lee I-M, et al. Association of step volume and intensity with all-cause mortality in older women. JAMA Internal Medicine, 2019.